Inhaled anesthetics, including the gaseous anesthetics nitrous oxide and xenon, are thought to act by interacting directly with ion-channel receptors. In contrast, little is known about the mechanism of action of inert gases that show only narcotic potency at high pressures, such as nitrogen or argon. In the present study, we investigated the effects of selective ␥-aminobutyric acid (GABA) receptor antagonists on narcosis produced by nitrogen, argon, and nitrous oxide. Pretreatment with the competitive GABA A receptor antagonist gabazine (0.2 nmol) but not the GABA B receptor antagonist 2-hydroxysaclofen (10 nmol) increased the nitrogen and argon threshold pressure for loss-of-righting-reflex (P Ͻ 0.005) but had no effect on nitrous oxide narcosis. Pretreatment with the GABA A benzodiazepine receptor antagonist flumazenil (5 nmol) also increased the narcosis threshold pressure of argon (P Ͻ 0.025). Given that neither 2-hydroxysaclofen, gabazine, nor flumazenil at the doses used induced hyperexcitability, our results support a selective antagonism by gabazine and flumazenil of the narcotic action of nitrogen and argon. Some mechanisms of nitrogen and argon narcotic action might be similar to those of clinical inhaled anesthetics. (Anesth Analg 2003;96:746 -9) I nhaled anesthetics (1-3), including the gaseous anesthetics nitrous oxide and xenon (4,5), interact directly at one or more superfamilies of ion-channel receptors such as the ␥-aminobutyric acid type A (GABA A ) receptor or the N-methyl-d-aspartate (NMDA) glutamate receptors. In contrast, only a few studies have investigated the mechanism of action of inert gases that only show narcotic potency at high pressures. As a consequence, because of the MeyerOverton rule of a high correlation between hydrophobicity and narcotic potency, the traditional view is that inert gases that show only narcotic potency at high pressures dissolve in the cellular membrane, occupying or expanding its volume (6), and thereby indirectly disrupting the functioning of synaptic transmission.
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(Anesth Analg 2003;96:746 -9)
I nhaled anesthetics (1) (2) (3) , including the gaseous anesthetics nitrous oxide and xenon (4, 5) , interact directly at one or more superfamilies of ion-channel receptors such as the ␥-aminobutyric acid type A (GABA A ) receptor or the N-methyl-d-aspartate (NMDA) glutamate receptors. In contrast, only a few studies have investigated the mechanism of action of inert gases that only show narcotic potency at high pressures. As a consequence, because of the MeyerOverton rule of a high correlation between hydrophobicity and narcotic potency, the traditional view is that inert gases that show only narcotic potency at high pressures dissolve in the cellular membrane, occupying or expanding its volume (6) , and thereby indirectly disrupting the functioning of synaptic transmission.
To investigate the contribution of GABA transmission as a possible mechanism by which inert gases that only show narcotic potency at high pressures may act, we compared the effects of selective GABA receptor antagonists gabazine, flumazenil, and 2-hydroxysaclofen on narcosis induced by nitrogen and argon at increased pressure and that produced by nitrous oxide, which acts mainly through the NMDA glutamate receptor (4) in freely moving rats. Because narcosis by nitrogen or argon only occur at increased pressures, we further examined the effect of these GABA receptor antagonists at high helium pressures to discriminate whether these drugs might have favored the well known high helium pressure-induced hyperexcitability and thereby produced indirect antagonism of narcosis. Our data suggest that nitrogen and argon, but not nitrous oxide, may act directly by potentiating GABA neurotransmission at the GABA A receptor.
Materials and Methods
All animal use procedures were in accordance with The Declaration of Helsinki and the European Communities Council Directive No. 86/609/EEC. Male adult Sprague-Dawley rats (Iffa Credo, France) weighing 250 -300 g were used. They were housed socially by groups of 6 at 21°C Ϯ 0.5°C in Perspex home cages with light maintained on a 12-h light:dark cycle (light on from 7 am to 7 pm) and free access to food and water for at least 3 days before surgery.
Rats were anesthetized with intraperitoneal pentobarbital 30 mg/kg and intraperitoneal ketamine 100 mg/kg and mounted on a stereotaxic apparatus with the incisor bar set 3.9 mm below the horizontal zero. They were implanted with a stainless steel guide cannula (23-gauge) for intracerebroventricular (icv) drug infusion in the right lateral ventricle (A: 0.92, L: 1.4, V: 3.2 from Bregma (7)). The guide cannula was anchored to the skull with two stainless steel screws and dental cement, and a stainless steel wire stylet was inserted into the guide cannula to prevent occlusion. After surgery, the rats were housed individually in Perspex home cages with free access to food and water and allowed to recover for at least 5 days before being submitted to any experiment.
Drugs were purchased from Research Biochemicals Inc (RBI, Natick, MA) and delivered icv 10 min before compression (see below) in 5 L of phosphate-buffered saline solution at an injection rate of 2.5 L/min using an injection needle inserted through the cannula and a microsyringe and perfusion apparatus (PHD 2000, Harvard Apparatus, Holliston, MA). Drugs were injected icv to avoid systemic side effects. The following drugs selective for the GABA A or the GABA B receptor were used: the GABA A receptor antagonist gabazine that acts at the neurotransmitter recognition site, the GABA A receptor antagonist flumazenil that acts at the GABA A benzodiazepine site, and the GABA B receptor antagonist 2-hydroxysaclofen.
Because GABA receptor antagonists may cause hyperexcitability that could have affected the present investigations on narcosis, the effects of gabazine, 2-hydroxysaclofen, and flumazenil on basal locomotor activity were investigated during preliminary experiments. The rats were placed inside the pressure chamber (see below) maintained at normal pressure. The chamber was equipped with 2 individual Perspex activity cages, 0.25 m in diameter, in which piezoelectrical sensors were fixed under the floor to allow automatic recording of the rat's locomotor activity (8) .
Recordings were continued for 1 h after the drug infusion.
The experiments were conducted in a 50-L hyperbaric chamber fitted with 3 viewing portholes (maximum pressure: 20 MPa ϳ 200 atm). Oxygen of medical grade (Air Liquide, Paris, France) was controlled and maintained at a partial pressure of 0.030 MPa inside the pressure chamber, whereas carbon dioxide was kept at a value less than 300 ppm by continuously circulating chamber gases through a soda lime canister. A powerful fan ensured oxygen mixing with the added gases to produce narcosis or pressure-induced hyperexcitability.
Narcosis was induced using either nitrogen, argon, or nitrous oxide of medical grade (Air Liquide) at a dose just sufficient to induce total loss-of-rightingreflex, a reliable criterion of narcosis. Nitrogen and argon were admitted in the pressure chamber at a compression rate of 0.1 MPa/min, whereas nitrous oxide was admitted at a compression rate of 0.016 MPa/min. The chamber was equipped with a Perspex cylinder of 0.3 m in diameter in which 4 freely moving rats could be rotated individually at 1 m/min. To avoid interactions between temperature and anesthesia, the temperature inside the chamber was adjusted to maintain rectal temperature at 37°C Ϯ 1°C in one additional restrained rat.
Because narcosis produced by nitrogen or argon only occur at increased pressures, the effect of gabazine, 2-hydroxysaclofen, and flumazenil were investigated at high helium pressures. Hyperbaric helium produces hyperexcitability that may affect both the sensory and motor aspects of a reflex. The rats were exposed to helium up to 4 MPa (the approximative pressure required to induce loss-of-righting-reflex with nitrogen) at a rate of 0.1 MPa/min and recorded as described above (8) only for locomotor activity; as a consequence, the sensory component was not studied. The temperature inside the pressure chamber was progressively increased from ambient temperature to 33°C to prevent hypothermia because of the significant specific heat of helium compared with air and to maintain the comfort of the rats.
Data are expressed as mean Ϯ sem. The effects of gabazine, flumazenil, and 2-hydroxysaclofen on nitrogen, argon, and nitrous oxide narcosis were expressed as percentage changes and analyzed using the nonparametric Mann-Whitney U-test. The level of significance was set at P Ͻ 0.05 (9) .
Results
Because GABA receptor antagonists may lead to hyperexcitability that could have affected the present investigations on narcosis, the effects of gabazine, 2-hydroxysaclofen, and flumazenil on basal locomotor activity were investigated during preliminary experiments. As shown in Table 1 , neither flumazenil 0.1, 1, or 5 nmol nor 2-hydroxysaclofen 0.1, 1, or 10 nmol produced arousal or hyperexcitability; in contrast, administration of gabazine 0.4 and 0.5 nmol, but not 0.1 and 0.2 nmol, resulted in an increase in locomotor activity and the additional development of clonic or clonic-tonic seizures. Given these data, the following doses were chosen for subsequent experiments on gas (Table 2 ). Both these absolute and relative anesthetic potencies are in agreement with previous data in rodents (10, 11) and the Meyer-Overton rule of a high correlation between hydrophobicity and anesthetic potency (10) . Pretreatment with gabazine resulted in a highly significant increase of the nitrogen threshold pressure and argon threshold pressure for the onset of loss-of-rightingreflex (P Ͻ 0.005), which were increased, respectively, by 13% and 15% compared with the control rats injected with saline alone but had no significant effect on narcosis induced by nitrous oxide. Pretreatment with flumazenil resulted in a modest, but significant, increase of the threshold pressure of argon, which was increased by 7% (P Ͻ 0.025) compared with control rats injected with saline but had no significant effect on narcosis produced by nitrogen or nitrous oxide (14 Ͻ U Ͻ 18; not significant). Pretreatment with 2-hydroxysaclofen showed no significant effect on narcosis produced by either nitrogen, argon, or nitrous oxide.
Because narcosis produced by nitrogen or argon only occur at increased pressures, the effects of gabazine, 2-hydroxysaclofen, and flumazenil were investigated at equivalent helium pressures to discriminate whether these drugs, at the doses that induced no arousal at normobaric pressure, might have produced hyperexcitability at increased pressures. Compared with control rats, helium at a pressure up to 4 MPa (the pressure approximatively required to induce loss-of-righting-reflex with nitrogen as a phase) produced a significant increase in locomotor activity (P Ͻ 0.02) that is part of the highpressure neurological syndrome (12) . Pretreatment with gabazine, 2-hydroxysaclofen, or flumazenil produced no additional hyperexcitability (Table 3) .
Discussion
Pretreatment with the GABA A receptor antagonist gabazine, but not the GABA B receptor antagonist 2-hydroxysaclofen, led to a significant increase of the nitrogen and argon threshold pressure for the onset of loss-of-righting-reflex but did not change the threshold pressure of nitrous oxide. In addition, pretreatment with flumazenil, an antagonist of the GABA A receptor at the benzodiazepine site, increased the threshold pressure of argon for loss-of-righting-reflex but had no effect on the threshold pressures of nitrogen or nitrous oxide. Alternatively, pretreatment with gabazine, 2-hydroxysaclofen, or flumazenil at the doses used to modulate narcosis produced no hyperexcitability at normal or hyperbaric pressures up to 4 MPa (the approximative pressure required to induce loss-of-righting-reflex with nitrogen). Our flumazenil data agree with a previous report (13) . Neither 2-hydroxysaclofen nor gabazine have been investigated at high helium pressures. Our data support a pharmacologic, rather than a physiologic, antagonistic action of gabazine and flumazenil on narcosis induced by argon and nitrogen at increased pressures. These findings may be consistent with either a direct or indirect mechanism of action on GABA A receptors. Indeed, it may still be plausible to interpret our data as identifying one of the synaptic functions that nitrogen and argon disrupt by dissolving in the cell membrane. However, the fact that neither gabazine nor flumazenil had a significant effect on narcosis induced by nitrous oxide, which acts via the NMDA receptor, further suggests that nitrogen and argon may interact directly with the GABA A receptor to produce loss-of-righting-reflex. In addition, our results also suggest that argon, but not nitrogen, may produce its narcotic action by interacting partly, but not exclusively, with the benzodiazepine site of the GABA A receptor; this suggests that argon may bind at multiple discrete sites on the GABA A receptor. The fact that the competitive GABA A receptor antagonist gabazine increased the narcotic threshold pressure of nitrogen and argon, whereas flumazenil, which acts at the benzodiazepine site of the GABA A receptor, only enhanced the narcotic threshold pressure of argon, may indicate that nitrogen and argon do not bind, at least partly, at the same discrete sites on the GABA A receptor. Although plausible, this hypothesis remains to be proven. Our results extend recent reports suggesting that nitrogen may induce its sedative subanesthetic action on locomotor activity by interacting with the GABA A , but not the GABA B , receptor (14, 15) and further shows that the GABA A receptor is poorly affected by nitrous oxide, which mainly produces its narcotic effect through the NMDA glutamate receptor (4, 5) .
In conclusion, the findings of the present study are consistent with the general consensus that has emerged during the past few decades that inhaled anesthetics produce their action by acting directly at one or more superfamilies of ligand ion-channels. That the sensitivity of ion-channel receptors, including the GABA A receptor, to inhaled anesthetics may be modulated by specific mutations in the channel receptor domains (16 -18) , with the sensitivity of the receptor to anesthetics being increased as hydrophobicity increases, together with our findings, lead us to believe that some mechanisms of action of inert gases that only show narcotic potency at high pressures might be shared with those of volatile and gaseous clinical anesthetics. No significant effect was found.
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